Baaritaanka VAP-da ee Baaritaanka Raajada (Cholesterol) ma Ogtahay Dhibaatadaada Cudurada Wadnaha?
Baaritaanka "VAP" ee baarista "cholesterol", ama imtixaanka gawaarida otomaatigga ah, ayaa faahfaahin dheeraad ah ka helaya baaritaanka caadiga ah ee "cholesterol" ama "lipid". Waxaa ka mid ah cabbiraadyo u hoggaansan yoolalka daaweynta cusub ee kolesteroolka waxaana laga yaabaa inay doorbidaan bixiyeyaasha daaweynaya daaweynta kolestaroolka sare. Waxay awood u yeelan kartaa inay aqoonsadaan dad badan oo khatar ugu jira jirada wadnaha ee mustaqbalka.
Imtixaanka auto-test profile (VAP) waxaa sameeyay cilmi-baarayaasha Birmington, Alabama oo ganacsi ahaan u soo bandhigay Atherotech, Inc. Suuq-geynta waxaa ansixiyay FDA 2007-dii.
Tijaabada VAP-ga Marka Loo Bixiyo Marka Lipid Profile for Cholesterol
Baadhitaanka caadiga ah ee cholesterolku wuxuu u shaqeeyaa dhiig daadinta oo leh xarig si deg deg ah oo dheellitiran si loo kala saaro lipids (dufanka). Imtixaankan heerka caadiga ah, oo lagu magacaabo lipid profile, wuxuu kala saaraa saddex qaybood oo lipid ah : lipoproteins-ka sareeya, ama HDL; lipoproteins hooseeya, ama LDL; iyo triglycerides, qaabka ugu weyn ee baruurta ee jirka.
Laakiin in ku dhow kala badh dadka oo dhan oo ay soo gaareen wadno-qabad wadnaha, ayaa muujinaya sawirka caadiga ah ee aan caadi ahayn. Sida laga soo xigtay Atherotech, imtixaanka VAP wuxuu awoodi doonaa inuu aqoonsado laba qof oo ka mid ah shakhsiyaadka khatarta ugu jira cudurka wadnaha, marka la barbardhigo farsamooyinka dhaqameed.
Qiyaasaha tijaabada ah ee "cholesterol"
- Heerarka LDL
- Wadarta Heerarka HDL
- Heerarka Triglyceride
Imtixaanka caadiga ah ee cholesterol, heerarkan waxaa lagu xisaabiyaa iyadoo la adeegsanayo naqshad gaar ah. Taas bedelkeeda, imtixaanka cusub ee VAP wuxuu si toos ah u cabbiri karaa heerarkaas.
Sidee u shaqeeyaa imtixaanka VAP
Sida muuqaalka dabiiciga ah, baaritaanka VAP wuxuu u shaqeeyaa isagoo ku riixaya saamiga dhiigga si uu u kala saaro lipids miisaanka. Laakiin imtixaanka VAP wuxuu bixiyaa faahfaahin ka badan tijaabada dhaqameed.
Tusaale ahaan, imtixaanka VAP wuxuu qiyaasayaa kolestaroolka LDL by cabbirka qiyaasta iyo sidoo kale wuxuu jebiyaa kolestaroolka HDL hoos hoose ee darajooyinka. Cilmi-baarisyada hadda jira waxay muujinayaan in qaababka qiyaasood ee qaybaha LDL ay muujin karaan halis weyn oo ah horumarinta cudurka wadnaha. Intaa waxaa dheer, hal qowmiyad oo HDL, HDL2, waxaa loo tixgeliyaa inay tahay gaar ahaan wadnaha ilaalinta.
Imtixaanka VAP wuxuu sidoo kale cabbirayaa qaar ka mid ah lipids-ka in profile-ka hadda laf dhabarta, sida lipoprotein-ka hooseeya (VLDL); lipoprotein dhexdhexaad ah (IDL); iyo lipoprotein (a) [Lp (a)]. Cilmi baadhayaasha Atherotech ayaa sheegaya in la qiyaasayo fasallada dheeraadka ah ee dabiiciga ah iyo darajooyinka hoose ay muujin karaan macluumaad dheeraad ah oo ku saabsan khatarta ah in uu ku dhaco cudurka wadnaha, taas oo imtixaanka dhaqanku maqnaanayo.
Waa maxay Tallaabooyinka imtixaanka VAP
- Wadarta VLDL: Heerarka sare ee VLDL ayaa u dhiganta khatarta sii kordheysa ee cudurada wadnaha iyo macaanka.
- Isugeynta Wadarta Wadarta Xanuunada: Wadarta heerka HDL, LDL iyo VLDL.
- Wadarta aan ahayn HDL: Wadarta qiyaasaha kaliya ee LDL iyo VLDL; qiimaha ka sarreeya wuxuu muujinayaa halis weyn oo ah inuu ku dhaco cudurka wadnaha.
- Total apoB100: Apolipoprotein B100 wuxuu caawiyaa abuurista, qaadaa oo keenaa "kolestarool xun" unugyada; cabbiraadda heerarka apoB100 ayaa ku caawinaya sidii loo ogaan lahaa nooca iyo / ama keenista kolestaroolka sare.
- Lp (a) cholesterol: Cilmi baaris ayaa soo jeedinaysa in Lp (a), oo la mid ah LDL, waa qodob halis ah oo loo yaqaan 'atherosclerosis'.
- IDL: Lipoprotein ee cufnaanta dhexe; sida laga soo xigtay Atherotech, tiradani waxay sare u kacdaa dadka shakhsiyaadka qaba cudurka macaanka ee qoyska.
- LDL-RC: LDL oo ku xidhan borotiin C-reactive; Nooca noocan ah ee LDL waxaa laga helaa goobta dabaqyada atherosclerotic ee jirka, kuwaas oo ah mid ka mid ah astaamaha muhiimka ah ee cudurka halbowlaha - iyo marka ay dillaacaan - bilaabida koowaad ee wadnaha wadnaha.
- Sum Total LDL-C: Wadarta Lp (a), IDL iyo LDL.
- LDL Size Pattern: Looga wargaliyay mid ka mid ah saddex qaybood - A, A / B ama B. Xaaladda A, maadooyinka LDL waa mid aad u yar oo aan yarayn, taas oo ka dhigaysa inay u fududaadaan jirka in ay ka saarto. Jumlad ahaan A / B, waxaa jira isku dhaf ah maaddooyinka iftiinka iyo cufan. Qaabka B, yaryar, miisaaniyado yaryar oo culus ayaa sare u kacaya. Sida laga soo xigtay Atherotech, bukaanada leh qaybo yar oo cufan oo LDL ah (qaab B) waxay leeyihiin hal khatar ah oo halis ugu jira inay ku dhacaan cudurka wadnaha marka loo eego bukaanka qaba qaabka cabbirka LDL A.
- HDL-2: Qeyb ka mid ah "kolestarool wanaagsan" oo si gaar ah looga hortago cudurrada wadnaha. Nambar yar oo halkan ka mid ah ayaa macnaheedu noqon karaa khatarta sii kordheysa ee cudurka halbowlaha wadnaha, xitaa kuwa qaba heerarka kale ee kolestaroolka caadiga ah.
- HDL-3: Qayb kale oo ka mid ah HDL, oo aan ka difaacayn cudurrada halbowlaha wadnaha illaa heerka HDL-2.
- VLDL-3: Lipoprotein-ka qanjirada aad u hooseeya ee triglyceride; Daraasadaha qaarkood waxay soo jeedinayaan isku-xirnaan suurtagal ah ee u dhexeeya lambarrada VLDL-3 iyo horumarka sonkorowga.
Sidoo kale, imtixaanka VAP wuxuu dadka siiyaa fikrad wanaagsan oo ay u nugul yihiin astaamaha dheef-shiid kiimikaadka , isku-dhafan oo isugeynaya oo si aad ah kor ugu qaadaya khatarta shakhsiga uu ku dhici doono cudurka macaanka ama cudurada wadnaha.
Xeerarka ujeeddooyinka daaweynta cholesterol ee ka soo baxa Warbixinta Consensus ee ADA / ACC 2008 ayaa waxaa ka mid ah bartilmaameedyada LDL-C, non-HDL-C iyo APOB, kuwaas oo ku jira VAP laakiin aaney qayb ka ahayn baaritaannada hoose ee kolestaroolka.
Ilaha:
Bioletto, Silvana, Alain Golay, Robert Munger, Barbara Kalix iyo Richard W. James. "Cudurka Hyperinsulinemia iyo Cufan aad u hooseeya iyo Mawduuca Lipoprotein ee Lafoprotein ee Mawduucyada Cuntada." Somali Journal of Nutrition Clinical 71 (2000): 443-449.
Crider, Kristin. "Lipoprotein Phenotype iyo Genotype." CDC.gov. 2 Nofembar 2007. Xarumaha Xakamaynta Cudurada.
"Xaashida Xaqiiqda: Baaritaanka VAP ee Baaritaanka Ragga. Imtixaanka Baaritaanka Joogtada ah ee Joogtada ah - VAP . 2008. Atherotech, Inc.
Kulkarni, KR, DW Garber, SM Marcovina iyo JP Segrest. "Tirada Kalamur-tirka ee dhammaan fasalada Lipoprotein ee habka VAP-II." Wargeyska Cilmi-baarista Lipid. 35 (1994) 159-168.
> Mayo Clinic Staff. "Baaritaanka Cholesterol: Kala saarista Lipids." MayoClinic.com . 1 Febraayo 2007. Mayo Clinic.
"Metabolic Syndrome." Cudurka Metabolic . 2014. Ururka wadnaha ee Maraykanka.
Singh, SK, MV Suresh, B Voleti iyo A Agrawal. "Xidhiidhka u dhexeeya C-reaktif Protein iyo Atherosclerosis." Annals of Medicine. 40.2. 16 NOV 2007 110-120.
Ziajka, Paul. "Iyadoo la adeegsanayo Baaritaan Dheecaan ah oo VAP ah oo ka yimid Atherotech si loo sameeyo Qorsho Daaweyn Daaweynta Bukaanka." 2008. Atherotech.